CAMBRIDGE, Mass., Dec. 5, 2017 /PRNewswire/ — Goldfinch Bio, a company focused on precision therapies to treat patients with kidney disease, today announced the appointments of industry veterans Anthony Johnson, M.D., to president and chief executive officer, and Michael Broxson to chief…
